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a b s t r a c t 
We report the crystal structure of the ﬁrst prokaryotic aspartic proteinase-like domain identiﬁed in 
the genome of Mycobacterium tuberculosis . A search in the genomes of Mycobacterium species showed 
that the C-terminal domains of some of the PE family proteins contain two classic DT / SG motifs of
aspartic proteinases with a low overall sequence similarity to HIV proteinase. The three-dimensional 
structure of one of them, Rv0977 (PE PGRS16) of M. tuberculosis revealed the characteristic pepsin- 
fold and catalytic site architecture. However, the active site was completely blocked by the N-terminal 
His-tag. Surprisingly, the enzyme was found to be inactive even after the removal of the N-terminal His- 
tag. A comparison of the structure with pepsins showed signiﬁcant differences in the critical substrate 
binding residues and in the ﬂap tyrosine conformation that could contribute to the lack of proteolytic 
activity of Rv0977. 
C © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical 
Societies. Open access under CC BY-NC-ND license.. Introduction 
Aspartic proteinases from several eukaryotes and retroviruses 
ave been extensively studied. They perform a variety of functions 
nd are implicated in a number of diseases. Aspartic proteinases uti- 
ize two aspartate residues to cleave the peptide bond with the help 
f a water molecule. The active site is formed between two domains, 
ach contributing one catalytic aspartate. In the case of HIV proteinase 
HIV PR), a homodimer is formed by two polypeptide chains whereas 
n eukaryotic aspartic proteases such as pepsin, a single polypeptide 
hain forms the two domains. It has been postulated that the eukary- 
tic aspartic proteinase has evolved by gene duplication and fusion of 
n ancestral gene into a single gene that encodes a single polypeptide 
hain [ 1 ]. Recently there have been a few reports on the presence of 
spartic proteinases in bacteria [ 2 , 3 ]. However, structural characteri- 
ation of these enzymes has not been reported. It is presumed that the 
tructure of the prokaryotic aspartic proteinase might be useful in un- 
erstanding the evolution of the aspartic proteinases from retroviral 
rotease to eukaryotic proteinases. 
A search in the genome of Mycobacterium tuberculosis with HIV PR 
equence as a query, picked a sequence in the C-terminal domain of a 
E PGRS protein, Rv0977, with low similarity. PE PGRS (polymorphic * Corresponding author. Tel.: + 91 80 22932838; fax: + 91 80 23600535. 
E-mail addresses: suguna@mbu.iisc.ernet.in , sugunakaza@gmail.com (K. Suguna). 
211-5463    c© 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of Europe
ttp://dx.doi.org/10.1016/j.fob.2013.05.004 GC-rich repetitive sequence) proteins form the largest subfamily of 
the PE family. The PE family is a large family of proteins identiﬁed 
for the ﬁrst time in the genome of M. tuberculosis accounting for 
∼6% of potentially coding genes of the genome [ 4 ]. The name PE is 
derived from the motif Pro-Glu (PE) found near the N-terminus in 
most of the PE proteins [ 4 ]. These are found exclusively in pathogenic 
mycobacterial species [ 5 ] thus presenting tremendous possibilities to 
be probed as drug targets. All members of the PE protein family have 
a highly conserved N-terminal domain of 110 amino acid residues, 
followed by a C-terminal segment that varies in size. In addition to PE 
domains, PE PGRS proteins have multiple tandem repeats of GGAGGX 
(where X = any amino acid) motif in the C-terminal segment [ 6 ]. In 
the case of Rv0977, this repeat is followed by an additional sequence 
at the C-terminus, which consists of two signature motifs of pepsins, 
DTG and DSG. 
Rv0977, a member of the PE PGRS family of proteins, was identi- 
ﬁed as one of the surface antigens of M. tuberculosis , and was found to 
be expressed in high levels during infection [ 7 ]. Though not many PE 
or PE PGRS proteins are characterized, a limited number of reports are 
available on the levels of expression of Rv0977, host response and its 
involvement in antigenic variation [ 5 , 8 ]. Rv0977 was shown to have 
protective immune response which was attributed to the unique se- 
quence present in the C-terminal domain but the exact nature of this 
domain was unknown. We have identiﬁed this domain to be a pu- 
tative aspartic proteinase and named it Mtb-AP, and determined its 
structure. an Biochemical Societies. Open access under CC BY-NC-ND license.
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Table 1 
Data collection and reﬁnement statistics. 
Data collection SAD data set 
Space group P 2 1 2 1 2 1 
Cell dimensions 
a , b , c ( ˚A) 61.11, 66.16, 69.62 
Wavelength ( ˚A) 0.978 
Resolution ( ˚A) 37.73–1.98 
R sym 0.132 (0.415) 
a 
I / σI 16.3 (6.9) 
Completeness (%) 100 (100) 
Redundancy 14.6 (14.3) 
Reﬁnement 
Resolution ( ˚A) 37.73–1.98 
No. reﬂections in working set 19,397 
No. reﬂections in test set 1044 
R work / R free 0.16 / 0.21 
No. atoms 
Protein 1970 
Zn 2 + 1 
Ethylene glycol 124 
Water 209 
B -factors ( ˚A 2 ) 
Protein 16.30 
Zn 2 + 7.05 
Ethylene glycol 38.47 
Water 28.39 
R.m.s. deviations 
Bond lengths ( ˚A) 0.017 
Bond angles (˚) 1.62 
a Values in parentheses are for the highest resolution shell. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2. Materials and methods 
2.1. Cloning and protein puriﬁcation of Mtb-AP 
The region of M. tuberculosis genomic DNA (58536–59354) en-
coding the predicted aspartic proteinase domain was ampliﬁed by
PCR using speciﬁc forward and reverse primers and was cloned into
pET-28a ( + ) vector. The gene sequence, conﬁrmed by sequencing
was 819 base pairs. The clone was transformed into the BL21 (DE3)
strain of Escherichia coli . The transformed cells were grown in Luria
Bertani (LB) broth at 37 ◦C, and protein expression was induced with
isopropyl- β- d -1-thiogalactopyranoside (IPTG) to a concentration of
100 μM and grown at 12 ◦C. Cells were harvested following 8–10 h of
induction. The pellet was resuspended in lysis buffer (20 mM Tris–HCl
(pH 7.4), 500 mM NaCl and 5 mM imidazole). Cells were lysed by son-
ication and the lysate was centrifuged at 14,000 g at 4 ◦C for 30 min.
The supernatant was loaded on to a Ni-NTA-agarose column and the
column was washed with buffer including the same components as
that of lysis buffer and subsequently with 20 mM Tris–HCl (pH 7.4),
500 mM NaCl, 20 mM imidazole and eluted with elution buffer con-
taining 20 mM Tris–HCl (pH 7.4), 500 mM NaCl, 100 mM imidazole.
The eluted protein was dialysed against a buffer containing 20 mM
Tris–HCl (pH 7.4) and 300 mM NaCl. 
Se-Met incorporated protein was prepared by metabolic inhibition
method. Cells were grown at 37 ◦C in M9 medium supplemented with
glucose and Kao and Michayluk vitamin Solution (Sigma). A mixture
of amino acids for inhibiting methionine biosynthetic pathway was
added to the culture when OD 600 reached 0.6. l -Selenomethionine
(Sigma) 25 mg / L and 100 μM IPTG were added an hour later and cells
were grown for further 10 h at 12 ◦C. Puriﬁcation of Se-Met incor-
porated enzyme was carried out following the protocol used for the
native enzyme. The selenomethionine incorporation was conﬁrmed
by mass determination using Electro Spray Ion-Mass Spectrometry
(ESI-MS). 
2.2. Cloning and protein puriﬁcation of Mtb-AP without tag 
To obtain a construct devoid of the His-tag, the reverse primer
containing a stop codon was used along with the previously used for-
ward primer to amplify the gene. The ampliﬁed product was cloned
into pET - 22b ( + ) vector. Due to the presence of stop codon in the
reverse primer the expressed protein did not have the C-terminal
His-tag present in the pET-22b ( + ) vector. The clone devoid of His-
tag was conﬁrmed by sequencing. It was transformed into the BL21
(DE3) strain of E. coli cells. The cells were grown and induced similar
to His-tagged protein. The pelleted cells were resuspended in lysis
buffer containing 25 mM Bis–Tris buffer (pH 6.0). Cells were lysed
by sonication and the lysate was centrifuged at 14,000 g at 4 ◦C for
30 min. The supernatant was loaded onto a Q-Sepharose anion ex-
change column and washed with buffer containing 25 mM Bis–Tris
buffer (pH 6.0). The protein was eluted with NaCl gradient from 0 to
1 M by using a gradient mixer. The eluted fractions were loaded on to
a SDS–PAGE. The fractions containing Mtb-AP were pooled, concen-
trated and loaded onto a Sephacryl S-200 HR gel ﬁltration column.
The pure fractions obtained from gel-ﬁltration were used for assay
and crystallization. 
2.3. Crystallization and data collection of Mtb-AP His-tagged construct 
Crystals of Mtb-AP were obtained in microbatch method by mix-
ing 2 μl of 6 mg / ml of protein with 2 μl of solution consisting of
0.1 M MES buffer pH 6.5 and 12% PEG 20K (Hampton Research Crystal
Screen2, condition # 26). This condition was optimized to get diffrac-
tion quality crystals. The native crystals diffracted to a resolution of
2.7 A˚ at home source. Selenomethionine incorporated protein also
crystallized in the native condition. SAD data were collected for thesecrystals on BM-14 situated at the European Synchrotron Radiation
Facility (ESRF), Grenoble, France. 
2.4. Structure solution and reﬁnement 
The diffraction data were processed using iMosﬂm [ 9 ] and the
structure was solved using the SAS protocol of Auto-Rickshaw [ 10 ].
The input diffraction data were prepared and converted for use in
Auto-Rickshaw using programs of the CCP4 suite [ 11 ]. FA values were
calculated using the program SHELXC [ 12 ]. All of the six heavy atoms
were found using the program SHELXD [ 13 ]. About 96% of the model
was built using the program ARP / wARP [ 14 ]. This model was further
reﬁned using REFMAC5 [ 15 ] from the CCP4 suite, followed by iterative
cycles of manual rebuilding using Coot [ 16 ] and reﬁnement. Solvent
molecules were identiﬁed by the automatic water-picking algorithm
of Coot. The positions of these automatically picked solvent molecules
were manually checked, and a few more were identiﬁed on the basis
of electron density contoured at 1.0 σ in the 2 F o − F c map and 3.0 σ in
the F o − F c map. Data collection and reﬁnement statistics are shown
in Table 1 . The geometry of the ﬁnal model was checked with Mol-
Probity [ 17 ]. There were 96% of residues in the favored region of the
Ramachandran plot, with the remaining 4% being in the allowed re-
gion. All structural ﬁgures were prepared using PyMOL (Schr ¨odinger).
Structural superpositions were carried out using ssm algorithm of the
program Coot [ 16 ]. 
2.5. Activity assays 
The activity of Mtb-AP was tested using denatured haemoglobin,
bovine serum albumin (BSA), casein ﬂuorescein isothiocyanate (FITC-
Casein), oxidized insulin B-chain and an HIV PR substrate in the pH
range 3–7, by adjusting the pH of the substrate solution using 0.1 M
citrate buffer and 0.1 M Tris buffer. For denatured haemoglobin, the
assay was carried out at pH 3 and 4 only as it precipitates beyond
pH 4. The protocol with each of these substrates is brieﬂy explained
below. All the assays were performed at 37 ◦C. 
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Fig. 1. Identiﬁcation of aspartic proteinase domain in M. tuberculosis . (A) BLAST search 
results showing the sequence alignment of HIV proteinase with M. tuberculosis PE-PGRS 
protein, Rv0977. The signature motif DTG is shown in bold and underlined. (B) Domain 
organization of the three PE-family proteins of M. tuberculosis having the aspartic 
proteinase domain. .5.1. Haemoglobin 
40 μl of Mtb-AP (100 μg ml −1 ) was added to 400 μl of 0.5% de- 
atured haemoglobin and incubated for various time periods (2, 4, 
, 12 and 16 h). The reaction was stopped at respective time inter- 
als by adding 800 μl of 5% trichloroacetic acid (TCA). The precipi- 
ate obtained after addition of TCA was removed by centrifugation 
t 13,000 rpm for 10 min. Pepsin at a concentration of 10 μg ml −1 
as used as a positive control. For each reaction, blank was set up 
n which TCA was added prior to enzyme addition. The absorbance 
f TCA soluble peptides in the supernatant in each test reaction was 
ecorded at 280 nm against the respective blanks [ 18 , 19 ]. 
.5.2. BSA 
40 μl of 100 μg ml −1 Mtb-AP was added to 400 μl of 0.5% BSA so- 
ution and incubated for different time periods (2, 4 and 8 h) [ 20 ]. The 
est of the steps were essentially similar to that of the Haemoglobin 
ssay. 
.5.3. FITC-Casein 
10 μl of 100 μg ml −1 Mtb-AP was added to 40 μl of 0.25% FITC- 
asein (Sigma) and incubated for 60 min. Then, 150 μl of 10% TCA was 
dded to the mixture and further incubated for 60 min. This mixture 
as then centrifuged for 10 min at 13,000 rpm. 10 μl of the super- 
atant was added to 10 ml of 500 mM Tris, pH 8.5. The ﬂuorescence 
mission was recorded at 525 nm by excitation at 490 nm. Blank 
or each sample was setup without addition of the enzyme. Trypsin 
10 μg ml −1 ) was used as a positive control for which the reaction 
as carried out at pH 8. 
.5.4. Oxidized insulin B chain 
This assay was carried out following the protocol described earlier 
 21 ]. 10 μl of 100 μg ml −1 of Mtb-AP was added to 40 μl of 100 μg ml −1 
xidized insulin B chain and incubated for various time periods (2, 4 
nd 6 h). The assay was terminated by immersing the tubes in an ice 
ath followed by addition of 700 μl of borate buffer, pH 9.2 and 100 μl 
f ﬂuorescamine (Sigma) dissolved in acetone (0.3 mg ml −1 ). Fluo- 
escence emission was measured at 475 nm by excitation at 395 nm. 
lank was setup for all the reactions without addition of the enzyme. 
s a positive control, 0.5 μg ml −1 of pepsin was used. Aliquots were 
aken at different time points post incubation and analysed for sub- 
trate cleavage by mass spectrometry. 
.5.5. HIV-1 PR substrate 
The substrate of HIV-1 PR (His-Lys-Ala-Arg-Val-Leu*NPhe-Glu- 
la-Nle-Ser) was a kind gift from Dr M.V. Hosur, BARC, Mumbai, 
ndia. The assay was carried out following the protocol described 
arlier [ 22 ]. 1 μg of Mtb-AP was added to 200 μM of HIV PR sub- 
trate solution at different pH and incubated. UV absorption spectra 
n the wavelength range 250–350 nm were recorded for the reaction 
ixture after 2 h of incubation. Decrease in absorbance at 310 nm 
ndicates the hydrolysis of the scissile peptide bond. As a control, 
bsorbance at 310 nm was measured for the substrate alone. 
.6. Pepstatin binding assay 
Mtb-AP without His-tag in 20 mM Tris pH 7.4, 300 mM NaCl was 
djusted to different pH (3, 4, 5, 6 and 7) using 0.05 M citrate buffer 
nd 0.05 M Tris buffer. The enzyme at a concentration of 0.5 mg ml −1 
n different pH buffers was applied to columns containing pepstatin 
garose equilibrated with the corresponding pH buffers. The column 
as washed with 10 bed volumes of buffer of respective pH and the 
rotein was eluted with 0.1 M Tris–HCl buffer pH 8.6, containing 1 M 
aCl. The eluted fractions and the agarose beads were loaded on to 
 SDS PAGE and the protein was visualized by silver staining [ 19 ]. 
epsin was used as a positive control. The His-tagged Mtb-AP served 
s a negative control. 3. Results and discussion 
A BLAST search carried out using pepsin sequences as query did 
not give any positive hits in the Mycobacterium genomes. However, 
a search with the sequence of HIV PR indicated a weak similarity to 
the protein Rv0977 of M. tuberculosis with only 15 residues being 
identical between the two sequences ( Fig. 1 A). In addition to the 
PE and PGRS domains, Rv0977 has a C-terminal domain with two 
aspartic proteinase motifs, one DTG and one DSG, one of them being 
picked by the sequence search. The length of the polypeptide chain 
of this domain with 273 residues is intermediate to that of pepsins 
( ∼325 residues) and HIV PR (2 ×99 residues). The two aspartates are 
separated by 154 residues. A search with the sequence of this domain 
revealed the presence of similar domains in two other proteins of 
M. tuberculosis , Rv1983 (PE PGRS35) and Rv2519 (PE26) ( Fig. 1 B), and 
also in other species of Mycobacterium ( Table S1 ). All the proteins that 
were identiﬁed to contain this domain belong to the PE family. The 
occurrence of this domain consistently in a single family of proteins 
in various mycobacterial species encouraged us to take up further 
analysis of this putative aspartic proteinase domain. 
The genes corresponding to the aspartic proteinase domains of 
the three M. tuberculosis proteins have been cloned and expressed. 
Only the domain from Rv0977 could be obtained in soluble form. The 
puriﬁed N-terminal His-tagged protein, however, showed no activity 
with many aspartic proteinase substrates such as haemoglobin, BSA, 
insulin B chain, FITC-Casein or with the HIV PR substrate [ 22 ], His- 
Lys-Ala-Arg-Val-Leu*NPhe-Glu-Ala-Nle-Ser. Structural studies were 
simultaneously pursued by setting up crystallization trials. Diffraction 
data to a resolution of 2.7 A˚ were collected from a crystal grown in one 
of the Hampton screen conditions (0.1 M MES buffer pH 6.5 and 12% 
PEG 20K). Molecular replacement attempts using the structures of 
pepsins or retroviral proteinases as search models were unsuccessful. 
Since there are six methionines in the sequence, a Se-Met derivative 
was prepared and data were collected to 1.98 A˚ resolution ( Table 1 ) 
at BM14 beamline of ESRF, Grenoble. 
The structure of Mtb-AP solved by SAD phasing revealed the fold 
and the catalytic site architecture typical of pepsins ( Fig. 2 ). There 
are 23 extra residues from the vector at the N-terminus of the cloned 
fragment of 273 residues of the protein domain. Electron density for 
the region −21 to −10 which includes the six histidine residues from 
the tag and from residues 3 to 271, except Ala266 was seen clearly. 
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Fig. 2. Crystal structure of Mtb-AP shown in cartoon representation. The catalytic 
aspartates, the bound His-tag residues (green) are shown in stick representation and 
the bound zinc ion as a grey sphere. (For interpretation of the references to colour in 
this ﬁgure legend, the reader is referred to the web version of this article.) 
Fig. 3. Stereo image of the coordination of the zinc atom with His-tag residues and 
catalytic aspartates. 2 F o − F c electron density map contoured at 2.0 σ level is shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. The interdomain β-sheet topology of pepsin and Mtb-AP. The ﬁrst β-strand of 
the C-terminal domain is shown in pink. 
Fig. 5. Structure-based sequence alignment of pepsin, Mtb-AP and HIV proteinase. 3 10 
helices are highlighted in yellow. (For interpretation of the references to colour in this 
ﬁgure legend, the reader is referred to the web version of this article.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 No density was observed for the side chains of Asn83, Leu85, Asn122,
Pro125, Thr265, Ile267 and Thr271. Unexpectedly, the hexahistidine
tag was found to occupy the entire substrate binding pocket with two
of the histidines and the catalytic aspartates coordinating a Zn 2 + ion
( Fig. 3 ), located at the position of the catalytic water molecule found in
the crystal structures of other aspartic proteinases. The active site of
the protein was completely blocked as evident from the crystal struc-
ture thus explaining the lack of activity of the protein. The presence
of Zn 2 + ion in the active site was unexpected, as the crystallization
condition does not contain the ion. Neither the culturing medium
nor the puriﬁcation buffers had Zn 2 + ion, hence it is likely that the
Zn 2 + ion was taken up from the cell. The presence of zinc ion was
conﬁrmed by atomic absorption spectroscopy. Similar coordination
between the catalytic residues and the Zn 2 + ion is observed in histo-
aspartic proteinase of Plasmodium falciparum [ 23 ]. In this structure,
apart from the catalytic His32 and Asp215, a water molecule and the
side chain of Glu278 from a neighbouring molecule interact with the
Zn 2 + ion. 3.1. The overall fold 
The fold of the domain is closer to pepsins than to retroviral pro-
teases with one exception in topology ( Fig. 4 ). A six stranded β-sheet is
formed between the N- and the C-terminal of Mtb-AP by three strands
from each domain. The predominantly β-sheet structure including
the unique ψ -loops which harbour the catalytic aspartates and the
hydrophobic-hydrophobic-glycine (HHG) motif [ 24 ] is retained in the
present structure except that the HHG motif of the C-terminal domain
is replaced by Asn-Thr-Gly residues. There are three 3 10 -helices and
three α-helices in Mtb-AP. One of the α-helices, His250-Gln256 of the
C-terminal domain, connected to the central β-strand of the interdo-
main β-sheet ( Fig. 4 ) is conserved in pepsins as well as in HIV PR. The
other two α-helices are in similar positions to those in pepsins. The
location of two of the three 3 10 -helices, Ser129-Met134 and Pro135-
Asn139, corresponds to a single α-helix in pepsins, the break being
caused by the proline residue at 135 ( Fig. 5 ). The third 3 10 -helix aligns
with the long loop in pepsins which has an α-helix and a 3 10 -helix
( Fig. 5 ). The loop lengths of Mtb-AP seem to lie between those of the
retroviral proteins ( Fig. 6 A) and pepsins ( Fig. 6 B). 
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Fig. 6. Stereo view of the structural superposition of (A) Mtb-AP (pink) on HIV pro- 
teinase dimer (green) and (B) Mtb-AP (pink) on Pepsin (cyan). Longer loops in each 
superposition are highlighted. (For interpretation of the references to colour in this 
ﬁgure legend, the reader is referred to the web version of this article.) 
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Fig. 7. Interaction between the catalytic aspartate with the HHG motif residues in the 
C-terminal domain (A) Pepsin and (B) Mtb-AP. Residues involved in hydrogen bonding 
interactions are shown in stick representation. Hydrogen bonds are shown as dashed 
lines. .2. The interdomain β-sheet topology 
Six antiparallel β-strands form a large β-sheet between the N and 
he C-terminal domains in the case of eukaryotic aspartic proteinases. 
he C-terminal domain of Mtb - AP has a different topology with two 
-strands of the sheet arranged parallel to each other ( Fig. 4 ), a conse- 
uence of the loop between the N- and the C-terminal domains being 
horter. Thus, this structure represents a new subclass of the aspartic 
roteinase family. 
.3. The histidine-tag 
The N-terminal residues −21 to −16 form a short helix which in- 
ludes three histidine residues ( −18 to −16) of the His-tag. The other 
hree histidine residues from −15 to −13 are in an extended con- 
ormation. Two of the histidine residues ( −16 and −14) coordinate 
ith the Zn 2 + ion present at the active site ( Fig. 3 ) In addition, the 
is-tag peptide is stabilized by a few more interactions with the pro- 
ein atoms and many interactions with solvent molecules ( Fig. S1 ). 
xtended peptides of similar size were found to occupy the binding 
ockets in propepsin [ 25 ] and a high pH form of cathepsin D [ 26 ] in
hich a lysine residue directly interacts with the catalytic aspartates. 
Subsequently, the protein was expressed without the His-tag and 
uriﬁed using ion exchange and gel ﬁltration. The puriﬁed protein 
ppears to be well-folded with a predominantly β-sheet structure 
imilar to the His-tagged construct as observed in the CD spectrum 
 Fig. S2 ) and free of Zn 2 + ion as conﬁrmed by atomic absorption 
pectroscopy. However, no activity was detected with the substrates 
isted above. Also, the protein did not bind to a pepstatin-agarose 
olumn indicating that it is pepstatin-insensitive. 
.4. The HHG motif 
The residues Val-Leu-Gly present in the N-terminal HHG motif 
f Mtb-AP are similar in nature to those in the eukaryotic aspartic proteinases. The HHG motif of the C-terminal domain is replaced by 
Asn-Thr-Gly residues in Mtb-AP. In pepsins, the amide nitrogens of 
the catalytic aspartates are hydrogen bonded to the backbone car- 
bonyl oxygen of the HHG motif residue ( Fig. 7 A) but in Mtb-AP the 
amide nitrogen of catalytic Asp189 is hydrogen bonded to the O γ
atom of Thr248 from the HHG motif ( Fig. 7 B). This threonine is con- 
served in all predicted aspartic proteinases of Mycobacterium species 
( Fig. S3 ). In pepsins, the side chain of a conserved Thr218 (pepsin 
numbering) makes a hydrogen bond with the side chain of catalytic 
Asp215 (pepsin numbering) ( Fig. 7 A). The proposed function of the 
hydrogen bond is to make the aspartate negatively charged at low 
pH [ 27 ]. In Mtb-AP, this threonine residue is replaced by a glycine 
(Gly192). The residue Asn247 of Mtb-AP which replaces the ﬁrst hy- 
drophobic residue of the conserved C-terminal HHG motif found in all 
other aspartic proteases, plays the role of Thr218 of pepsins in making 
a hydrogen bond with the catalytic Asp189 ( Fig. 7 A). This asparagine 
is also conserved in all mycobacterial aspartic proteinases ( Fig. S3 ). 
3.5. The substrate binding site and activity 
A comparison of the structure of Mtb-AP with its structural equiva- 
lents human pepsin (PDB code: 1PSO ) and rhizopuspepsin (PDB code: 
3APR ) in complex with inhibitors showed that the subsites of Mtb- 
AP appear to be similar to those of reported pepsins [ 28 , 29 ] with 
some small but signiﬁcant differences ( Fig. 8 and Table S2 ). S 1 : The 
ﬂap residue tyrosine (Tyr64) along with glycine (Gly66) is well con- 
served in the family of eukaryotic aspartic proteinases. Mtb-AP has 
an additional alanine (Ala65) between Tyr64 and Gly66 ( Fig. S4 ). A 
phenylalanine insertion corresponding to Ala65 of Mtb-AP was ob- 
served in the case of cockroach allergen Bla g 2 which was found to 
be inactive [ 30 ]. When pepstatin was docked in the binding pocket 
of Mtb-AP, the Ala65 side chain and the ﬂap Tyr64 were found to 
make short contacts with it. The side chain of the conserved ﬂap 
tyrosine has a different conformation ( χ1 = 173 ◦) when compared 
to that ( χ1 = −54 ◦ in porcine pepsin) of eukaryotic aspartic pro- 
teinases ( Fig. S5 A). This conformation is stabilized by the hydrogen 
bond between tyrosine hydroxyl group and the side chain of the cat- 
alytic Asp36. Similar conformation of tyrosine was also observed in 
the crystal structures of chymosin [ 31 ] and saccharopepsin [ 32 ] ( Fig. 
S5 B) and was postulated to be responsible for keeping the enzymes 
in a self-inhibited state. The alanine insertion along with the altered 
conformer of tyrosine makes the S 1 pocket narrower and hence, it 
is difﬁcult for the substrate to enter the active site. S 2 : The O γ atom 
of Thr77 of porcine pepsin makes a hydrogen bond with the amide 
nitrogen of P 2 residue. This threonine is either an aspartate or a serine 
in other pepsins, but is replaced by a glycine (Gly67) in Mtb-AP ( Fig. 
8 ). S 3 : The position occupied by Ile193 of Mtb-AP is generally a Thr / 
Ser / Asn, the side chain of which makes a conserved hydrogen bond 
with substrate backbone nitrogen atom of P 3 residue. This substrate 
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Fig. 8. Differences in the subsite residues of Mtb-AP (magenta) and rhizopuspepsin 
(violet). Residues equivalent to Ile130 and Trp194 of rhizopuspepsin are absent in Mtb- 
AP because of truncated loops. (For interpretation of the references to colour in this 
ﬁgure legend, the reader is referred to the web version of this article.) 
Fig. 9. Surface representation of the active site of (A) Mtb-AP and (B) rhizopuspepsin 
(PDB code: 3APR ). A modiﬁed peptide inhibitor of rhizopuspepsin is shown at a struc- 
tural equivalent site in Mtb-AP. Ile193 of Mtb-AP which forms the mouth of S 3 pocket 
is shown with arrow. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 stabilizing interaction is lost in Mtb-AP due to the presence of Ile193.
Moreover, Ile193, which forms the mouth of S 3 subsite projects out,
occluding the S 3 subsite ( Fig. 9 ). S 1 
′ : This subsite contains the ﬁrst
hydrophobic residue present in the conserved C-terminal HHG motif
of eukaryotic aspartic proteinases. In Mtb-AP, the hydrophilic residue
Asn247 which replaces the ﬁrst residue of the C-terminal HHG mo-
tif forms the S 1 
′ pocket ( Fig. 8 ). Thus we can speculate that Mtb-AP
might require a hydrophilic residue at P 1 
′ position. S 2 ′ : Some of the
residues of S 2 
′ pocket which can interact with and stabilize the sub-
strate are either not conserved or absent because of the deletion of
the loops and thus making this binding pocket wide open ( Fig. 9 ).
These differences could contribute to the lack of activity of Mtb-AP. 
Similar to Mtb-AP, proteolytic activity was not detected in most
of the members of an extensive family of proteins, the pregnancy-
associated glycoproteins (PAGs) even though their sequences are
about 50% identical to pepsins [ 33 , 34 ]. Changes in the DTG motif
explain the lack of activity in some cases (Asp215 to Gly in ovine
PAG-1, Gly34 to Ala in bovine PAG-1 and porcine PAG-1). In a few
other PAGs with conserved catalytic site residues, the presence of the
sequence EPV instead of QDL for the residues 148–150 of pepsins was
suggested to be the cause of inactivity [ 35 ]. This region is involved in
interactions between the two domains and any changes in this region
might affect interdomain orientation altering the function. However,proteolytic activity was reported recently in three PAGs, bovine PAG-
2 & PAG-12 [ 36 ] and porcine PAG-2 [ 37 ], all of them having the EPV
sequence, when a modiﬁed peptide was used as the substrate. 
4. Conclusions 
The polypeptide chain of Mtb-AP is shorter than the eukaryotic
proteases. However, the fold of the enzyme has been preserved by
shortening of the loops. The parallel arrangement of two strands in the
interdomain β-sheet topology instead of the antiparallel arrangement
present in all aspartic proteinases has happened because of shortened
loop length but to preserve the same fold. The hydrophilic residues
Asn247 and Thr248 substituted in place of hydrophobic residue of the
C-terminal HHG motifs have been conserved in all predicted aspartic
protease domains of Mycobacterium species. These two residues play
a crucial role in preserving the hydrogen bonds made by Asp189, a
structural feature essential for catalysis and to maintain the active
site geometry. 
The alanine insertion in the ﬂap region along with the altered con-
formation of tyrosine, compared to pepsins, are likely to contribute to
the inactivity of the protein by preventing the entry of the substrate
into the active site. In addition, the critical substrate binding residues
of the S 2 and S 3 pockets of pepsins are different in Rv0977 and thus
the enzyme may not be able to bind the substrate strongly. These
residues in Rv2519 and MMAR 1538 are similar in nature to those in
pepsins. Hence, it is likely that these proteins could be active. 
With the fold and the required geometry of the catalytic site strik-
ingly similar to known aspartic proteinases, it is unlikely that Mtb-AP
lacks any protease activity. Though it was found to be insensitive to
common pepsin substrates, it is possible that Mtb-AP has a narrow
speciﬁcity which could be detected with an appropriate substrate.
However, it is clear that further extensive investigations are required
to establish the substrate speciﬁcity of the protein if it turns out to be
an aspartic proteinase, or to ﬁnd whether it has an entirely different
function in vivo to understand the exact mechanism of host–pathogen
interaction involving Mtb-AP. As in the case of PAGs, smaller pep-
tides might be required instead of protein substrates to detect the
activity especially when the activity is weak. Even though the pro-
teolytic cleavage occurs between two speciﬁc residues, detection of
new speciﬁcities is not trivial as it is necessary to generate and screen
a large number of longer peptides as the interactions on either side of
the scissile bond are also crucial for binding. The wider binding pocket
in Mtb-AP makes it even more difﬁcult to explore and establish its
exact substrate speciﬁcity. 
The unique features outlined above makes the M. tuberculosis pro-
tein distinctly different from the others in terms of substrate speci-
ﬁcity, which needs to be explored. A small number of pepsin-like
bacterial aspartic proteinases have been reported, but no structure is
available so far. The structure of Mtb-AP supports the hypothesis [ 3 ]
suggested while reporting the newly identiﬁed single chain aspartic
prtoteinases in bacteria that the bacterial and eukaryotes might have
diverged after gene duplication and fusion event. In spite of the lack
of detection of the function, it is important to report the discovery
of the aspartic proteinases in the pathogenic mycobacterial species,
especially since the three-dimensional structure reveals the poten-
tial of the protein to be an aspartic proteinase with two aspartates
optimally positioned for catalysis. As Rv0977 has been identiﬁed as
the surface antigen, it could become a potential target for designing
drugs against tuberculosis once the in vivo function is established. 
Accession code . The coordinates and structure factors of Mtb-AP
have been deposited in the Protein Data Bank with accession code
PDB: 4EHC . 
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